Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1996 Aug;117(1):173–177. doi: 10.1017/s095026880000128x

Impact of incomplete coverage of neonatal dried blood spot screening on estimating HIV-1 seroprevalence.

E J Hutchinson 1, A Streetly 1, C Grant 1, R Pollitt 1, P Eldridge 1, A Nicoll 1
PMCID: PMC2271670  PMID: 8760966

Abstract

The aim of this study was to determine the extent to which selective under-coverage of births to mothers more likely to be at risk of HIV-1 infection will result in a significant under-estimation of the true neonatal seroprevalence. Census data, local birth statistics, maternity data and data from the prevalence monitoring programme were used to produce a model to predict the effects of under-coverage in the uptake of neonatal metabolic screening which has been observed in babies with a mother of ethnic group black African. The adjustment factor which allows for under-coverage is the relative inclusion ratio (RIR); the probability that samples from a group at different risk of HIV infection were included in the survey divided by the probability of inclusion for samples from all other babies. The RIR was found to be close to unity (0.97), indicating a minimal bias. Under usual conditions only if the relative inclusion ratio (RIR) declined to values of 0.87 or below would there be a substantial bias. Despite some selective under representation, the results obtained from the Unlinked Anonymous HIV Monitoring Programme Dried Blood Spot Survey would seem to identify levels of prevalence in the population of child-bearing women with a good degree of accuracy and remains a useful tool for resource allocation, planning of services, provision of care and counselling.

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E., Davison C. F., Holland F. J., Gibb D. M., Hudson C. N., Nicholl A., Goldberg D., Peckham C. S. Vertically transmitted HIV infection in the British Isles. BMJ. 1993 May 15;306(6888):1296–1299. doi: 10.1136/bmj.306.6888.1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ades A. E., Parker S., Berry T., Holland F. J., Davison C. F., Cubitt D., Hjelm M., Wilcox A. H., Hudson C. N., Briggs M. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet. 1991 Jun 29;337(8757):1562–1565. doi: 10.1016/0140-6736(91)93260-g. [DOI] [PubMed] [Google Scholar]
  3. Ades A. E. Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):490–499. [PubMed] [Google Scholar]
  4. Dondero T. J., Gill O. N. Large-scale HIV serologic surveys: what has been learned? AIDS. 1991;5 (Suppl 2):S63–S69. doi: 10.1097/00002030-199101001-00010. [DOI] [PubMed] [Google Scholar]
  5. Dunn D. T., Nicoll A., Holland F. J., Davison C. F. How much paediatric HIV infection could be prevented by antenatal HIV testing? J Med Screen. 1995;2(1):35–40. doi: 10.1177/096914139500200110. [DOI] [PubMed] [Google Scholar]
  6. Elliman D., Garner J. Review of neonatal screening programme for phenylketonuria. BMJ. 1991 Aug 24;303(6800):471–471. doi: 10.1136/bmj.303.6800.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gibb D. M., Faulknall W., Nokes L., Appleby S., Holland F. J., Berry T., Ades A. E. Coverage of routine neonatal metabolic screening in children born to women known to be infected with HIV-1. Commun Dis Rep CDR Rev. 1995 Jul 21;5(8):R123–R124. [PubMed] [Google Scholar]
  8. Grant D. B., Smith I. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) 1988 May 14;296(6633):1355–1358. doi: 10.1136/bmj.296.6633.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pappaioanou M., Kashamuka M., Behets F., Mbala S., Biyela K., Davachi F., George J. R., Green T. A., Dondero T. J., Heyward W. L. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS. 1993 Apr;7(4):483–488. doi: 10.1097/00002030-199304000-00005. [DOI] [PubMed] [Google Scholar]
  10. Pass K. A., Schedlbauer L. M., MacCubbin P. A., Glebatis D. M. Comparison of newborn screening records and birth certificates to estimate bias in newborn HIV serosurveys. Am J Public Health. 1991 May;81 (Suppl):22–24. doi: 10.2105/ajph.81.suppl.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pharoah P. O., Madden M. P. Audit of screening for congenital hypothyroidism. Arch Dis Child. 1992 Sep;67(9):1073–1076. doi: 10.1136/adc.67.9.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Smith I., Cook B., Beasley M. Review of neonatal screening programme for phenylketonuria. BMJ. 1991 Aug 10;303(6798):333–335. doi: 10.1136/bmj.303.6798.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Streetly A., Grant C., Bickler G., Eldridge P., Bird S., Griffiths W. Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London. BMJ. 1994 Aug 6;309(6951):372–374. doi: 10.1136/bmj.309.6951.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Streetly A., Grant C., Pollitt R. J., Addison G. M. Survey of scope of neonatal screening in the United Kingdom. BMJ. 1995 Sep 16;311(7007):726–726. doi: 10.1136/bmj.311.7007.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tappin D. M., Girdwood R. W., Follett E. A., Kennedy R., Brown A. J., Cockburn F. Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet. 1991 Jun 29;337(8757):1565–1567. doi: 10.1016/0140-6736(91)93261-7. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES